Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年2月3日
	新闻
	FDA Approves Subcutaneous Injection of Lung Cancer Treatment | Research | AACR American Association for Cancer Research (AACR) FDA approved amivantamab and hyaluronidase-lpuj for subcutaneous injection to treat certain cases of EGFR-mutated non-small cell lung cancer. 标记为不相关
	What Have You or Someone Close to You Done to Prevent Cancer? We Asked the Experts. CU Anschutz newsroom ... Oncology: Prior to moving into a new home, I have the location tested for radon, which is a cause of lung cancer. Because one home was above the ... 标记为不相关
	Novel Cancer Vaccine Receives FDA Orphan Drug Designation in Cutaneous Melanoma CancerNetwork IFx-2.0 showed a clinical benefit in an early phase 1 trial and has now been given orphan drug designation by the FDA for patients with stage IIB ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈